Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and N-[[3-(4-fluorophenyl)-1-phenyl-4-pyrazolyl]methyl]-1-phenylmethanamine

rosiglitazone has been researched along with N-[[3-(4-fluorophenyl)-1-phenyl-4-pyrazolyl]methyl]-1-phenylmethanamine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, J; Lee, HS; Park, Y; Yang, Y; Yoon, S1

Other Studies

1 other study(ies) available for rosiglitazone and N-[[3-(4-fluorophenyl)-1-phenyl-4-pyrazolyl]methyl]-1-phenylmethanamine

ArticleYear
1,3-Diphenyl-1H-pyrazole derivatives as a new series of potent PPARĪ³ partial agonists.
    Bioorganic & medicinal chemistry, 2010, Dec-01, Volume: 18, Issue:23

    Topics: Binding Sites; Computer Simulation; HEK293 Cells; Humans; PPAR gamma; Protein Structure, Tertiary; Pyrazoles; Structure-Activity Relationship

2010